Skip to content
10-K/A

Annual Report

UNIGENE LABORATORIES INC

0001437749-13-000964

← back to feed
Filed
Jan 31, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Feb 29, 2012 95.37M sh
Shares Diluted FY 2011 · Dec 31, 2011 93.18M sh
Shares Diluted FY 2011 · Dec 31, 2010 91.96M sh
Shares Diluted FY 2011 · Dec 31, 2009 90.66M sh
Capex restated FY 2011 · Dec 31, 2011 $694.6K
Capex restated FY 2011 · Dec 31, 2010 $144.48K
Capex FY 2011 · Dec 31, 2009 $220.06K
Operating Cash Flow FY 2011 · Dec 31, 2011 −$6.77M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$1.67M
Operating Cash Flow FY 2011 · Dec 31, 2009 −$11.29M
Cash And Equivalents FY 2011 · Dec 31, 2011 $4.68M
Cash And Equivalents FY 2011 · Dec 31, 2010 $12.2M
Cash And Equivalents FY 2011 · Dec 31, 2009 $4.89M
Cash And Equivalents FY 2011 · Dec 31, 2008 $8.58M
Stockholders Equity restated FY 2011 · Dec 31, 2011 −$65.7M
Stockholders Equity restated FY 2011 · Dec 31, 2010 −$61.82M
Stockholders Equity FY 2011 · Dec 31, 2009 −$30.44M
Stockholders Equity restated FY 2011 · Dec 31, 2008 −$18.97M
Current Liabilities FY 2011 · Dec 31, 2011 $5.7M
Current Liabilities FY 2011 · Dec 31, 2010 $7.3M
Total Liabilities restated FY 2011 · Dec 31, 2011 $83.89M
Total Liabilities restated FY 2011 · Dec 31, 2010 $91.03M
Current Assets FY 2011 · Dec 31, 2011 $10.29M
Current Assets FY 2011 · Dec 31, 2010 $16.06M
Total Assets restated FY 2011 · Dec 31, 2011 $18.2M
Total Assets restated FY 2011 · Dec 31, 2010 $29.21M
Eps Diluted restated FY 2011 · Dec 31, 2011 −$0.08
Eps Diluted restated FY 2011 · Dec 31, 2010 −$0.35
Eps Diluted FY 2011 · Dec 31, 2009 −$0.15
Sga Expense FY 2011 · Dec 31, 2011 $8.89M
Sga Expense FY 2011 · Dec 31, 2010 $7.69M
Sga Expense FY 2011 · Dec 31, 2009 $8.94M
Rd Expense FY 2011 · Dec 31, 2011 $9.02M
Rd Expense FY 2011 · Dec 31, 2010 $6.43M
Rd Expense FY 2011 · Dec 31, 2009 $12.35M
Net Income restated FY 2011 · Dec 31, 2011 −$7.1M
Net Income restated FY 2011 · Dec 31, 2010 −$32.53M
Net Income FY 2011 · Dec 31, 2009 −$13.38M
Operating Income FY 2011 · Dec 31, 2011 −$3.47M
Operating Income FY 2011 · Dec 31, 2010 −$10.32M
Operating Income FY 2011 · Dec 31, 2009 −$12.38M
Cost Of Revenue FY 2011 · Dec 31, 2011 $1.55M
Cost Of Revenue FY 2011 · Dec 31, 2010 $2.61M
Cost Of Revenue FY 2011 · Dec 31, 2009 $2.17M
Revenue FY 2011 · Dec 31, 2011 $20.51M
Revenue FY 2011 · Dec 31, 2010 $11.34M
Revenue FY 2011 · Dec 31, 2009 $12.79M